FATE EPS Estimates
Fate Therapeutics, Inc.
$1.97
+$0.03(+1.29%)
40
Overall
60
Value
20
Tech
42
Quality
Market Cap
$232.45M
Volume
240.05K
52W Range
$0.95 - $3.23
Target Price
$5.74
FATE EPS estimates: the consensus estimate for Fate Therapeutics, Inc.'s current fiscal year is -$1.03 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
FATE EPS Estimates
- EPS estimate, current quarter
- $-0.27
- EPS estimate, next quarter
- $-0.30
- EPS estimate, current year
- $-1.03
- EPS estimate, next year
- $-1.01
- EPS growth, 3-year
- +26.62%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.15 |
| 2024 | $-1.64 |
| 2023 | $-1.64 |
| 2022 | $-2.91 |
| 2021 | $-2.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.97 | +1.3% | 240.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |